SENAMI EDALERE LUKULA: Open Payments
NPI 1942999784 · BOLINGBROOK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,139 in 30 payments from 12 companies in 2025. Trend: 2023 $142 · 2024 $1,359 · 2025 $1,139
Food & beverage: $1,139
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $301 |
| Axsome Therapeutics, Inc. | 4 | $284 |
| Teva Pharmaceuticals USA, Inc. | 2 | $127 |
| Otsuka America Pharmaceutical, Inc. | 1 | $126 |
| ABBVIE INC. | 5 | $97 |
| Supernus Pharmaceuticals, Inc. | 2 | $50 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Janssen Pharmaceuticals, Inc | 1 | $28 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
Products named: CAPLYTA, Auvelity, REXULTI, UZEDY, VRAYLAR, Qelbree, COBENFY, INVEGA SUSTENNA.
Industry payments across IL — which companies pay providers there.
